A Pilot Study to Evaluate the Efficacy of IZN 6D4 for the Treatment of Diabetic Foot Ulcers – “Journal of Diabetic Complications & Medicine”

January 11, 2018 10:14 amJanuary 11, 2018

The attached publication in the “Journal of Diabetic Complications & Medicine” by the authors Jonathan Rosenblum and Menachem Oberbaum describes the first ever experience with Curasite® in man. This pilot study led to the larger double blind effort that resulted in FDA approval of the product.

Curasite is also approved for the following over the counter (OTC) uses:

Minor abrasions

Minor lacerations

Minor cuts

Minor scalds and burns.

The FDA claims are extensive and importantly position Curasite as first line therapy for these patients. Due to the unprecedented efficacy of Curasite, Izun intends to pursue other indications for this remarkable wound healing product.